• Profile
Close

Low-dose propofol for pediatric migraine: A prospective, randomized controlled trial

The Journal of Emergency Medicine Feb 21, 2018

Sheridan DC, et al. - The efficacy of low-dose propofol (LDP) was compared to standard therapy (ST) in pediatric migraine treatment. Compared to ST, LDP did not achieve better pain reduction; however, LDP was associated with markedly fewer rebound headaches and a non-significant trend toward shorter median length of stay (LOS) from drug administration to disposition.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay